Journal of Molecular Diagnostics

Your source for applications of the latest technological advances to diagnostic questions and clinical solutions.

Highest Ranked Journal in its field!
Publishing Monthly since 2020!
Impact Factor (2023): 3.4
5-Year Impact Factor (2022): 4.9
CiteScore (2023): 8.1
2022 Eigenfactor: 0.0074

Editor-in-Chief,  Ronald M. Przygodzki, MD
Co-owned with The American Society for Investigative Pathology (ASIP), Published by Elsevier.

• Online Member Access

Members receive full access. Login required.
(Download login Instructions)

• JMD Online (Non-Member Access)
• Institutional Subscriptions
• JMD CME Program (this program will no longer be offered starting in 2024)

The Journal of Molecular Diagnostics (JMD), the official publication of the Association for Molecular Pathology, co-owned by the American Society for Investigative Pathology, publishes high-quality original papers on scientific advances in the translation and validation of molecular discoveries in medicine into the clinical diagnostic setting, and the description and application of technological advances in the field of molecular diagnostic medicine.

Articles report novel discoveries with direct application to clinical diagnostics or clinicopathologic correlations including studies in oncology, infectious diseases, hematopathology, inherited diseases, predisposition to disease, or the description of polymorphisms linked to disease states or normal variations; the application of diagnostic methodologies in clinical trials; and the development of new or improved molecular methods for diagnosis or monitoring of disease or disease predisposition.

Special Features include Technical Advances, a peer-reviewed section featuring novel methods to solve diagnostic dilemmas. Reviews, Commentaries, and Special Articles provide focus on controversial research topics.